Subscribe To
biocryst reports third quarter 2023 financial results and provides business update
– Q3 2023 ORLADEYO net revenue of $85.7 million (+29.8 percent y-o-y) — – Company expects to achieve no less than $320 million in full year 2023...
November 2, 2023, 11:00 am
biocryst to host r&d day on november 3
RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2023 (GLOBE NEWSWIRE) — biocryst Pharmaceuticals, Inc. (Nasdaq...
October 20, 2023, 11:00 am
biocryst (bcrx) surges 9.9%: is this an indication of further gains?
biocryst (BCRX) saw its shares surge in the last session with trading volume being higher than average....
September 19, 2023, 11:18 am
biocryst pharmaceuticals rallies on quebec reimbursement for orladeyo angioedema treatment
biocryst Pharmaceuticals (NASDAQ:BCRX) shares jumped in early Monday trading after it told investors th...
September 18, 2023, 10:53 am
biocryst pharmaceuticals, inc. (bcrx) q2 2023 earnings call transcript
biocryst Pharmaceuticals, Inc. (NASDAQ:BCRX ) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM E...
August 3, 2023, 12:55 pm
biocryst to report second quarter 2023 financial results on august 3
RESEARCH TRIANGLE PARK, N.C., July 20, 2023 (GLOBE NEWSWIRE) — biocryst Pharmaceuticals, Inc. (Nasdaq...
July 20, 2023, 11:00 am
biocryst selects er-kim pharmaceuticals as commercial partner for orladeyo® (berotralstat) in turkey
RESEARCH TRIANGLE PARK, N.C., July 19, 2023 (GLOBE NEWSWIRE) — biocryst Pharmaceuticals, Inc. (Nasdaq...
July 19, 2023, 11:00 am
biocryst to present new orladeyo® (berotralstat) data at 2023 european academy of allergy and clinical immunology congress
RESEARCH TRIANGLE PARK, N.C., May 31, 2023 (GLOBE NEWSWIRE) -- biocryst Pharmaceuticals Inc (Nasdaq: BC...
May 31, 2023, 7:02 am
Why biocryst pharmaceuticals stock is soaring today
biocryst Pharmaceuticals reported first-quarter earnings Wednesday morning. The financial report painte...
May 3, 2023, 1:44 pm
biocryst to report first quarter 2023 financial results on may 3
RESEARCH TRIANGLE PARK, N.C., April 19, 2023 (GLOBE NEWSWIRE) — biocryst Pharmaceuticals, Inc. (Nasda...
April 19, 2023, 11:00 am
biocryst to report first quarter 2023 financial results on may 3
RESEARCH TRIANGLE PARK, N.C., April 19, 2023 (GLOBE NEWSWIRE) -- biocryst Pharmaceuticals, Inc. (Nasdaq...
April 19, 2023, 7:00 am
biocryst appoints dr. nancy hutson as chair of the board
RESEARCH TRIANGLE PARK, N.C., March 31, 2023 (GLOBE NEWSWIRE) — biocryst Pharmaceuticals, Inc. (Nasda...
March 31, 2023, 11:00 am
biocryst: good candidate for buyout, but not for anything else
biocryst Pharmaceuticals, Inc. has one blockbuster potential marketed drug, but not much of a pipeline....
March 8, 2023, 2:01 pm
Why shares of biocryst pharmaceuticals jumped today
A day after the stock plummeted, it bounced back....
February 22, 2023, 3:29 pm
biocryst is not currently uncovering the full value of orladeyo
biocryst's main value driver, ORLADEYO, is already profitable in its second year on the market and gene...
February 22, 2023, 9:00 am
biocryst pharmaceuticals, inc. (bcrx) q4 2022 earnings call transcript
biocryst Pharmaceuticals, Inc. (NASDAQ:BCRX ) Q4 2022 Earnings Conference Call February 21, 2023 8:30 A...
February 21, 2023, 1:00 pm
Why biocryst pharmaceuticals stock is sinking today
Investors didn't like the drugmaker's Q4 update....
February 21, 2023, 11:55 am
biocryst pharmaceuticals (bcrx) reports q4 loss, tops revenue estimates
biocryst (BCRX) delivered earnings and revenue surprises of -100% and 6.11%, respectively, for the quar...
February 21, 2023, 9:47 am
Pharmaceutical stock sinks on sales forecast
biocryst Pharmaceuticals Inc (NASDAQ:BCRX) stock is sinking today, down 11.6% at $10.45 at last glance,...
January 9, 2023, 3:10 pm
biocryst pharmaceuticals: more aggressive growth for orladeyo
As a stellar drug for hereditary angioedema, biocryst Pharmaceuticals' Orladeyo is enjoying strong sale...
December 20, 2022, 4:47 pm